141 related articles for article (PubMed ID: 33545313)
1. Schisandrin B-mediated TH17 cell differentiation attenuates bowel inflammation.
Ma Z; Xu G; Shen Y; Hu S; Lin X; Zhou J; Zhao W; Liu J; Wang J; Guo J
Pharmacol Res; 2021 Apr; 166():105459. PubMed ID: 33545313
[TBL] [Abstract][Full Text] [Related]
2. Schisandrin B inhibits Th1/Th17 differentiation and promotes regulatory T cell expansion in mouse lymphocytes.
Chen Z; Guo M; Song G; Gao J; Zhang Y; Jing Z; Liu T; Dong C
Int Immunopharmacol; 2016 Jun; 35():257-264. PubMed ID: 27085037
[TBL] [Abstract][Full Text] [Related]
3. Suppression of MAPK and NF-κ B pathways by schisandrin B contributes to attenuation of DSS-induced mice model of inflammatory bowel disease.
Liu W; Liu Y; Wang Z; Yu T; Lu Q; Chen H
Pharmazie; 2015 Sep; 70(9):598-603. PubMed ID: 26492645
[TBL] [Abstract][Full Text] [Related]
4. Schisandrin A protects against lipopolysaccharide-induced mastitis through activating Nrf2 signaling pathway and inducing autophagy.
Xu D; Liu J; Ma H; Guo W; Wang J; Kan X; Li Y; Gong Q; Cao Y; Cheng J; Fu S
Int Immunopharmacol; 2020 Jan; 78():105983. PubMed ID: 31767544
[TBL] [Abstract][Full Text] [Related]
5. Schisandrin B promotes T
Guo J; Shen Y; Lin X; Chen H; Liu J
Int Immunopharmacol; 2021 Dec; 101(Pt A):108213. PubMed ID: 34624651
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of schisandrin B on the cardiac function in mice model of myocardial infarction.
Chen P; Pang S; Yang N; Meng H; Liu J; Zhou N; Zhang M; Xu Z; Gao W; Chen B; Tao Z; Wang L; Yang Z
PLoS One; 2013; 8(11):e79418. PubMed ID: 24260217
[TBL] [Abstract][Full Text] [Related]
7. Schisandrin B promotes Foxp3
Chiang CY; Chang JH; Chuang HC; Fan CK; Hou TY; Lin CL; Lee YL
Eur J Pharmacol; 2022 Mar; 918():174775. PubMed ID: 35085518
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo.
Zhu S; Wang Y; Chen M; Jin J; Qiu Y; Huang M; Huang Z
Am J Chin Med; 2012; 40(3):551-66. PubMed ID: 22745070
[TBL] [Abstract][Full Text] [Related]
9. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
Zhang D; Liu B; Cao B; Wei F; Yu X; Li GF; Chen H; Wei LQ; Wang PL
Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015
[TBL] [Abstract][Full Text] [Related]
10. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
Wu J; Jia J; Liu L; Yang F; Fan Y; Zhang S; Yan D; Bu R; Li G; Gao Y; Chen Y
J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effects of Schisandrin A, B, and C on Acne-Related Inflammation.
Guo M; An F; Wei X; Hong M; Lu Y
Inflammation; 2017 Dec; 40(6):2163-2172. PubMed ID: 28875271
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis.
Guo M; An F; Yu H; Wei X; Hong M; Lu Y
Biomed Pharmacother; 2017 Dec; 96():129-136. PubMed ID: 28972885
[TBL] [Abstract][Full Text] [Related]
13. Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3.
Dai X; Yin C; Guo G; Zhang Y; Zhao C; Qian J; Wang O; Zhang X; Liang G
Toxicol Appl Pharmacol; 2018 Nov; 358():110-119. PubMed ID: 30195018
[TBL] [Abstract][Full Text] [Related]
14. Differential Action between Schisandrin A and Schisandrin B in Eliciting an Anti-Inflammatory Action: The Depletion of Reduced Glutathione and the Induction of an Antioxidant Response.
Leong PK; Wong HS; Chen J; Chan WM; Leung HY; Ko KM
PLoS One; 2016; 11(5):e0155879. PubMed ID: 27195753
[TBL] [Abstract][Full Text] [Related]
15. Schizandrin B attenuates angiotensin II induced endothelial to mesenchymal transition in vascular endothelium by suppressing NF-κB activation.
You S; Qian J; Wu G; Qian Y; Wang Z; Chen T; Wang J; Huang W; Liang G
Phytomedicine; 2019 Sep; 62():152955. PubMed ID: 31146168
[TBL] [Abstract][Full Text] [Related]
16. Arctigenin exerts anti-colitis efficacy through inhibiting the differentiation of Th1 and Th17 cells via an mTORC1-dependent pathway.
Wu X; Dou Y; Yang Y; Bian D; Luo J; Tong B; Xia Y; Dai Y
Biochem Pharmacol; 2015 Aug; 96(4):323-36. PubMed ID: 26074264
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl
Zhang H; Chen Q; Dahan A; Xue J; Wei L; Tan W; Zhang G
Chem Biol Interact; 2019 Aug; 309():108675. PubMed ID: 31150632
[TBL] [Abstract][Full Text] [Related]
18. Schisandrin B Attenuates Inflammation in LPS-Induced Sepsis Through miR-17-5p Downregulating TLR4.
Ji ZR; Xue WL; Zhang L
Inflammation; 2019 Apr; 42(2):731-739. PubMed ID: 30506107
[TBL] [Abstract][Full Text] [Related]
19. Schisandrin B induces an Nrf2-mediated thioredoxin expression and suppresses the activation of inflammasome in vitro and in vivo.
Leong PK; Ko KM
Biofactors; 2015; 41(5):314-23. PubMed ID: 26307448
[TBL] [Abstract][Full Text] [Related]
20. Schisandrin B Attenuates Airway Inflammation by Regulating the NF-
Chen Y; Kong Y; Wang Q; Chen J; Chen H; Xie H; Li L
J Immunol Res; 2021; 2021():8029963. PubMed ID: 34258300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
